Skip to content
Search

Latest Stories

Green Party unveils ambitious NHS investment plan ahead of General Election

Green Party unveils ambitious NHS investment plan ahead of General Election
The Green Party envisions this investment as a means to ensure dignity for those in need and alleviate the burden on NHS services

The Green Party has previewed its upcoming manifesto with a bold proposal for the National Health Service (NHS) and social care system, promising an unprecedented level of investment to restore and enhance these critical services.

By 2030, the Greens aim to inject over £50 billion annually into health and social care, accompanied by an additional £20 billion capital investment to modernise healthcare infrastructure.


Green Party Co-Leader Adrian Ramsay emphasised the urgency of these reforms, stating, "Our NHS is at breaking point following 14 years of underfunding."

"Patients are stuck in hospital corridors, people can’t see their GP or NHS dentist when they need to, and staff are severely overstretched."

The manifesto highlights a comprehensive approach to revitalising the NHS, including:

A £30 billion annual increase for the NHS: This funding aims to raise salaries for frontline workers, ensuring rapid access to GPs and same-day service in urgent cases.

It also pledges universal access to NHS dental care.

Ramsay elaborated, "Greens believe passionately in the NHS and we are the only party to be honest with the public that it’s going to cost money to nurse the NHS back to health after 14 years of Conservative damage."

A £20 billion per year boost for social care: This proposal seeks to address the pressures on the NHS caused by an underfunded care system.

The Green Party envisions this investment as a means to ensure dignity for those in need and alleviate the burden on NHS services.

A £20 billion capital investment: The Greens plan to modernise aging hospitals and primary care facilities, as well as update outdated equipment, bringing them up to contemporary standards.

Co-Leader Carla Denyer underscored the Green Party's commitment to maintaining the public nature of the NHS, saying, "It is only the Greens who are offering a cast-iron guarantee to push back against the creeping privatisation of the NHS."

She contrasted this with other parties, noting, "Wes Streeting, the Shadow Health Secretary, said he would ‘hold the door wide open’ to an increased role for the private sector in our precious NHS."

Pallavi Devulapalli, the Green Party’s Health, Social Care and Public Health spokesperson and a practicing GP, shared her perspective on the impact of underinvestment:

"It breaks my heart when patients come into my surgery and I know they won’t get the care they need in a timely manner. But it doesn’t have to be like this."

"With the political will, we can have an NHS that puts the patient first and ensures world-beating quality of care," she added.

The Greens argue that their plans are not only necessary but also feasible, advocating for a fairer tax system to fund these substantial investments.

Ramsay concluded, "With more Greens in the next Parliament, we will press the new government to take the action needed to restore our NHS."

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less